FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
BENZODIAZEPINE ENZYME IMMUNOASSAY
K Number: K032365
·
Decision Sep 5, 2003
Classifications
1
FEI Numbers
90
Registration Numbers
90
Same Product Code
89
Applicant Total
50
Review Days
36
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- BENZODIAZEPINE ENZYME IMMUNOASSAY
- K Number
- K032365
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 862.3170
- Medical Specialty
- Clinical Toxicology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Lin-Zhi International, Inc.
- Date Received
- July 31, 2003
- Decision Date
- September 5, 2003
- Product Code
- JXM
- Advisory Committee
- Clinical Toxicology
- Review Advisory Committee
- TX
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| JXM | Enzyme Immunoassay, Benzodiazepine | FDA class 2 | Clinical Toxicology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (JXM), ordered by most recent decision date.
Alinity c Benzodiazepines Reagent Kit
FDA 510(k)
FDA Class 2
·Clinical Toxicology
ONLINE DAT Benzodiazepines II
FDA 510(k)
FDA Class 2
·Clinical Toxicology
CEDIA Benzodiazepine Assay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
DRI Benzodiazepine Assay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Psychemedics Microplate EIA for Benzodiazepines in Hair
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Healgen Multi-Drug Urine Test Cup; Healgen Multi-Drug Urine Test Dip Card
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Other Clearances by Lin-Zhi International, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K253082 | LZI Buprenorphine II Enzyme Immunoassay | Jan 16, 2026 | Substantially Equivalent |
| K251634 | LZI Fentanyl III Enzyme Immunoassay | Jun 18, 2025 | Substantially Equivalent |
| K202007 | LZI Oxycodone III Enzyme Immunoassay | Sep 17, 2020 | Substantially Equivalent |
| K201938 | LZI Fentanyl II Enzyme Immunoassay | Aug 7, 2020 | Substantially Equivalent |
| K201223 | LZI Tramadol Enzyme Immunoassay | Jun 4, 2020 | Substantially Equivalent |
| K192299 | LZI Cotinine II Enzyme Immunoassay | Nov 21, 2019 | Substantially Equivalent |
| K192433 | LZI Methadone II Enzyme Immunoassay | Oct 4, 2019 | Substantially Equivalent |
| K181159 | LZI Fentanyl Enzyme Immunoassay | Dec 3, 2018 | Substantially Equivalent |
| DEN170010 | LZI Carisoprodol Metabolite (Meprobamate) Enzyme Immunoassay | Apr 20, 2018 | Unknown |
| K170416 | LZI Methadone Metabolite Enzyme Immunoassay, LZI Methadone Metabolite (100 and 300) Calibrators | Jun 26, 2017 | Substantially Equivalent |